Thanks to advances in science and innovation, people living with HIV have options for effective treatment that mean they can expect to live long and healthy lives and achieve an undetectable viral load. We won’t stop developing the next generation of medicines to help everyone, everywhere.
THE POTENTIAL OF bNAbs
bNAb's (broadly neutralizing antibodies) can play a role in 2 key areas; the next generation of HIV treatments and cure research.
From data to day-to-day
Vani Vannappagari, head of Epidemiology and Real world evidence on the need to better understand medicines in real world settings.
THE FUTURE OF HIV MEDICINE
Watch Kimberly Brown and Bill Spreen discuss important advances in HIV care, and what the future looks like for treatment and prevention options.
YOU MIGHT ALSO BE INTERESTED IN
As the fight against HIV enters a new chapter, innovation, and the new therapies it brings, has the potential to transform the lives of those living with HIV.
Since the start of the HIV epidemic, researchers, scientists, and healthcare professionals have tirelessly worked to understand the virus and develop effective treatments.
Broadly neutralising antibodies, or bNAbs, can recognise and fight off many different strains of HIV, potentially making them effective tools in treatment and prevention. At ViiV Healthcare, researchers are exploring how bNAbs not only block the HIV virus from entering cells but also target hidden virus reservoirs in the body.
NP-GBL-HVX-COCO-240022 July 2025
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
